Cargando…
Liver injury caused by fenofibrate within 48 h after first administration: a case report
BACKGROUND: Fenofibrate is commonly used in the treatment of dyslipidemia. Fenofibrate is related to mild aminotransferase elevations and in some cases severe chronic injury such as fibrosis or cirrhosis, resulting in liver transplantation or death. The latency of disease has been reported to range...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323204/ https://www.ncbi.nlm.nih.gov/pubmed/34325660 http://dx.doi.org/10.1186/s12876-021-01874-7 |